Article Details
Retrieved on: 2024-12-08 00:03:59
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Poze-Cemdi is a first-in-class combination of an antibody and an siRNA targeting C5: pozelimab is a fully human monoclonal antibody designed to block ...
Article found on: www.globenewswire.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here